Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety evaluation of C11-HCA2969, a VLA-4-targeted PET probe, in healthy adults
jRCTs051250020Completed
- Start
- May 2025
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of C11-HCA2969. Primary endpoints: Whole-body effective dose estimation and Adverse events and side effects. Started May 2025; status: completed.
02
Drugs
C11-HCA2969
Beyond the preview
Go deeper on jRCTs051250020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051250020.